AbbVie · 1 day ago
2026 Analytical R&D LNP Characterization (PhD)
AbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines. They are seeking a highly motivated intern to drive innovation within analytical sciences, specifically focusing on mRNA-LNP characterization and the evaluation of multi-attribute instruments.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Develop methods such as DLS, MALS, Encapsulation, HPLC, to support the optimal LNP formulation
Evaluate the capabilities of a multi-attribute (MA) instrument to integrate with current analytical methodologies
Author SOP and update periodically at cross-functional meetings
Qualification
Required
Currently enrolled in university, pursuing a PhD in analytical chemistry or other related fields
Must be enrolled in university for at least one semester following the internship
Preferred
Expected graduation date between December 2026 – June 2027
Hands on experience in basic analytical methods to characterize LNP
Experience working with DLS, MALS, Encapsulation, HPLC
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2026-01-11
2026-01-09
2026-01-09
Company data provided by crunchbase